ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vi...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -29.2x | ||
| Revenue | 2.382 B | ||
| Net Income to Company | -117.7 M |
| ICUI | Peers | Sector | |
|---|---|---|---|
Market Cap | 3.437 B | 600.9 M | 64.173 M |
Price % of 52 Week High | 71.4% | 66.8% | 62.0% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | 1.8% | -1.8% | -0.7% |
1 Year Price Total Return | 30.6% | -15.2% | -12.3% |
Beta (5 Year) | 0.74 | 1.22 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 2,280 | 2,259 | 2,382 | 588 | 630 |
| Operating Income | (3.57) | 48 | 97 | (5.44) | 46 |
| Net Profit | (74) | (30) | (118) | (17) | (24) |
| Diluted EPS | -3.11 | -1.23 | -4.83 | -0.71 | -0.98 |
| EBITDA | 232 | 277 | 317 | 52 | 99 |
| Balance Sheet | |||||
| Cash & ST Invest. | 243 | 279 | 321 | 279 | 321 |
| Current Assets | 1,235 | 1,221 | 1,442 | 1,221 | 1,442 |
| Total Assets | 4,516 | 4,378 | 4,204 | 4,378 | 4,204 |
| Current Liabilities | 495 | 482 | 556 | 482 | 556 |
| Total Liabilities | 2,426 | 2,255 | 2,239 | 2,255 | 2,239 |
| Total Equity | 2,090 | 2,123 | 1,965 | 2,123 | 1,965 |
| Total Debt | 1,735 | 1,705 | 1,643 | 1,705 | 1,643 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (62) | 166 | 204 | 91 | 40 |
| Cash From Investing | (1,909) | (88) | (89) | (31) | (27) |
| Cash From Financing | 1,637 | (36) | (56) | (7.85) | (8.19) |
| Free Cash Flow | (152) | 82 | 125 | 61 | 16 |